Liye Ma

Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma.

The circular RNA PVT1/miR-203/HOXD3 pathway promotes the progression of human hepatocellular carcinoma.

Journal: Biology open
Published: September 26, 2019

Glucocorticoids promote the development of azoxymethane and dextran sulfate sodium-induced colorectal carcinoma in mice.

Glucocorticoids promote the development of azoxymethane and dextran sulfate sodium-induced colorectal carcinoma in mice.

Journal: BMC cancer
Published: June 09, 2018

Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.

Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.

Journal: Oncogene
Published: June 03, 2018

Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer.

Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer.

Journal: OncoTargets and therapy
Published: June 11, 2016

Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.

Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.

Journal: Oncotarget
Published: June 19, 2015

TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573.

TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573.

Journal: FEBS letters
Published: April 27, 2015

Genetic polymorphisms of XRCC1 gene and susceptibility to gastric cancer in Chinese Han population.

Genetic polymorphisms of XRCC1 gene and susceptibility to gastric cancer in Chinese Han population.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: August 08, 2013

Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.

Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.

Journal: Cancer
Published: April 06, 2013

Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.

Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)
Published: March 14, 2013

Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer.

Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer.

Journal: Tumori
Published: October 13, 2011
Showing 1-10 of 10

Last Updated: 09/26/2026